DC Field | Value | Language |
dc.contributor.author | Sprîncean, Mariana | |
dc.contributor.author | Stratulat, Petru | |
dc.contributor.author | Eţco, Ludmila | |
dc.contributor.author | Petrov, Victor | |
dc.contributor.author | Opalco, Igor | |
dc.contributor.author | Burlacu, Ala | |
dc.contributor.author | Paladi, Elena | |
dc.date.accessioned | 2019-06-22T09:36:58Z | |
dc.date.available | 2019-06-22T09:36:58Z | |
dc.date.issued | 2015 | |
dc.identifier.citation | SPRÎNCEAN, Mariana, STRATULAT, Petru, EŢCO, Ludmila, PETROV, Victor, OPALCO, Igor, et al. Neuroprotecţia antenatală cu sulfat de magneziu şi evaluarea neurologică la distanţă a copiilor prematuri. In: Sănătate Publică, Economie şi Management în Medicină. 2015, nr. 1(58), pp. 59-64. ISSN 1729-8687. | en_US |
dc.identifier.issn | 1729-8687 | |
dc.identifier.uri | http://repository.usmf.md/handle/20.500.12710/1644 | |
dc.identifier.uri | http://revistaspemm.md/wp-content/uploads/2019/04/cm1_58_2015-2.pdf | |
dc.description.abstract | In this bibliographic research is discussed the antenatal neuroprotection with sulphate of magnesium and neurological evaluation at distance of premature children. A big number of studies have demonstrated the positive role of antenatal administration of sulphate of magnesium as a fetal neuroprotector to women with a high risk of premature childbirth. The nature of neurological lesions is modified to premature children which were treated with magnesium sulphate at antenatal period, been neurologically evaluated at 1 year after birth. These children demonstrated a low level of risk for major neurological disorders. | en_US |
dc.description.abstract | Данное библиографическое исследование поднимает вопрос антенатальной нейропротекции сульфатом магния и дистанционного исследования недоношенных детей. Множество работ доказали положительную роль лечения женщин с высоким риском преждевременных родов сульфатом магния в качестве фетального нейропротектора. Сущность неврологических поражений меняется у той категории недоношенных детей, которые принимали антенатальное лечение сульфатом магния, которые были неврологически обследованы в возрасте 1-го года жизни. Данная категория детей представляет собой низкий уровень риска для серьёзных неврологических расстройств. | ru |
dc.language.iso | ro | en_US |
dc.publisher | Asociația Obștească "Economie, Management și Psihologie în Medicină" | en_US |
dc.relation.ispartof | Sănătatea Publică, Economie şi Management în Medicină | |
dc.subject | antenatal neuroprotection | en_US |
dc.subject | neurological evaluation | en_US |
dc.subject | premature child | en_US |
dc.subject | magnesium sulfate | en_US |
dc.subject.mesh | Infant, Premature | en_US |
dc.subject.mesh | Neuroprotection | en_US |
dc.subject.mesh | Magnesium Sulfate--therapeutic use | en_US |
dc.title | Neuroprotecţia antenatală cu sulfat de magneziu şi evaluarea neurologică la distanţă a copiilor prematuri | en_US |
dc.title.alternative | Antenatal neuroperotection with magnesium sulphate and distance neurological evaluation of premature children | en_US |
dc.title.alternative | Aнтенатальная нейропротекция сульфатом магния и дистанционное обследование недоношенных детей | en_US |
dc.type | Article | en_US |
Appears in Collections: | Sănătate Publică, Economie şi Management în Medicină Nr. 1 (58) / 2015
|